(NPR) – A new drug, called GanLum, was more than 97% effective at treating malaria in clinical trials carried out across 12 African countries, researchers reported Wednesday at the American Society for Tropical Medicine and Hygiene in Toronto. That’s as good, if not better, than the current standard of treatment. If approved by regulators, it could be a powerful new tool against a disease that kills roughly half a million people each year. (Read More)